Geron (GERN) Market Capitalization (2010 - 2026)
Geron's (GERN) quarterly Market Capitalization came in at $822.4 million in Q2 2026, down 8.59% year-over-year from $899.6 million in Q2 2025, and down 13.74% quarter-over-quarter from $953.4 million in Q1 2026.
Analysis
Geron (GERN) Market Capitalization (2010 - 2026) Analysis & Trends
Geron has disclosed Market Capitalization across 17 years of filings, most recently posting $822.4 million for Q2 2026.
- In Q2 2026, Market Capitalization fell 8.59% year-over-year to $822.4 million; the TTM figure through Jun 2026 stood at $822.4 million (down 8.59% YoY), while the FY2025 annual figure was $844.6 million, down 60.65% from the prior year.
- Market Capitalization came in at $822.4 million for Q2 2026 at Geron, down from $953.4 million in the prior quarter.
- In the past five years, Market Capitalization ranged from a high of $2.7 billion in Q3 2024 to a low of $513.3 million in Q1 2022.
- Average Market Capitalization over 5 years is $1.3 billion, with a median of $983.0 million recorded in 2025.
- Year-over-year, Market Capitalization jumped 186.88% in 2023 and plunged 68.13% in 2025.
- Over 5 years, Market Capitalization stood at $944.4 million in 2022, then climbed by 21.74% to $1.1 billion in 2023, then jumped by 86.7% to $2.1 billion in 2024, then plunged by 60.65% to $844.6 million in 2025, then decreased by 2.63% to $822.4 million in 2026.
- Per Business Quant data, the three most recent Market Capitalization figures were $822.4 million in Q2 2026, $953.4 million in Q1 2026, and $844.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 822.37 Mn |
| Mar 31, 2026 | 953.39 Mn |
| Dec 31, 2025 | 844.61 Mn |
| Sep 30, 2025 | 874.55 Mn |
| Jun 30, 2025 | 899.60 Mn |
| Mar 31, 2025 | 1.01 Bn |
| Dec 31, 2024 | 2.15 Bn |
| Sep 30, 2024 | 2.74 Bn |
| Jun 30, 2024 | 2.56 Bn |
| Mar 31, 2024 | 1.96 Bn |
| Dec 31, 2023 | 1.15 Bn |
| Sep 30, 2023 | 1.15 Bn |
| Jun 30, 2023 | 1.68 Bn |
| Mar 31, 2023 | 1.10 Bn |
| Dec 31, 2022 | 944.44 Mn |
| Sep 30, 2022 | 892.09 Mn |
| Jun 30, 2022 | 585.62 Mn |
| Mar 31, 2022 | 513.33 Mn |
| Dec 31, 2021 | 394.95 Mn |
| Sep 30, 2021 | 441.07 Mn |